Literature DB >> 25073510

miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.

Tingjia Cao1, Hanjun Li, Yilin Hu, Dandan Ma, Xun Cai.   

Abstract

MicroRNAs (miRNAs) play essential roles in the progression of hepatocellular carcinoma (HCC). miR-144 acts as a tumor suppressor in some malignancies, while its role in HCC is unclear. Here, we found that miR-144 was significantly decreased in HCC tissues and cell lines. Forced overexpression of miR-144 remarkably reduced cell proliferation, increased apoptosis, and suppressed migration and invasion of HCC cells. E2F transcription factor 3 (E2F3) was identified as a target of miR-144 in HCC cells. Moreover, E2F3 overexpression partially attenuated the tumor suppressive effects of miR-144, and the expression of E2F3 was negatively correlated with miR-144 level in HCC tissues. Our data suggest that miR-144 might suppress the growth and motility of HCC cells partially by targeting E2F3.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25073510     DOI: 10.1007/s13277-014-2017-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

2.  MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.

Authors:  Qian-Qian Zhang; Hui Xu; Mian-Bo Huang; Li-Ming Ma; Qiao-Juan Huang; Qing Yao; Hui Zhou; Liang-Hu Qu
Journal:  Neuro Oncol       Date:  2012-01-04       Impact factor: 12.300

3.  MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.

Authors:  Li Huang; Junhua Luo; Qingqing Cai; Qiuhui Pan; Hong Zeng; Zhenghui Guo; Wen Dong; Jian Huang; Tianxin Lin
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

4.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

5.  Curtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencing.

Authors:  Karuppaiya Vimala; Shenbagamoorthy Sundarraj; Mohanan V Sujitha; Soundarapandian Kannan
Journal:  Arch Med Res       Date:  2012-09-07       Impact factor: 2.235

6.  Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.

Authors:  B Pérez-Saborido; S Jiménez de los Galanes; J C Menéu-Díaz; C Jiménez Romero; A Moreno Elola-Olaso; Y Fundora Suárez; V Barra Valencia; E Moreno-González
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

7.  Amplification and overexpression of E2F3 in human bladder cancer.

Authors:  Andrew Feber; Jeremy Clark; Graham Goodwin; Andrew R Dodson; Paul H Smith; Anne Fletcher; Sandra Edwards; Penny Flohr; Alison Falconer; Toby Roe; Gyula Kovacs; Nening Dennis; Cyril Fisher; Richard Wooster; Robert Huddart; Christopher S Foster; Colin S Cooper
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

8.  MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.

Authors:  Xiao-Ying Huang; Jin-Guang Yao; Hong-Dong Huang; Chao Wang; Yun Ma; Qiang Xia; Xi-Dai Long
Journal:  Gastroenterol Res Pract       Date:  2013-09-24       Impact factor: 2.260

9.  MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Authors:  Fenqiang Xiao; Wu Zhang; Liming Chen; Fei Chen; Haiyang Xie; Chunyang Xing; Xiaobo Yu; Songming Ding; Kangjie Chen; Haijun Guo; Jun Cheng; Shusen Zheng; Lin Zhou
Journal:  J Transl Med       Date:  2013-08-22       Impact factor: 5.531

10.  miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.

Authors:  Angela M Liu; Zhi Xu; Felix H Shek; Kwong-Fai Wong; Nikki P Lee; Ronnie T Poon; Jinfei Chen; John M Luk
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more
  37 in total

Review 1.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

2.  miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.

Authors:  Zhiyong Liu; Jian Yi; Rong Ye; Jianping Liu; Qing Duan; Junqi Xiao; Fengen Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144.

Authors:  Feng Gao; Tao Wang; Zefeng Zhang; Rui Wang; Yang Guo; Junfeng Liu
Journal:  Tumour Biol       Date:  2015-08-08

4.  miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.

Authors:  Xin Wu; Chang-Lei Cui; Wei-Lun Chen; Zhong-Ying Fu; Xiang-Yan Cui; Xu Gong
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

5.  miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

Authors:  Suna Zhou; Wenguang Ye; Yanjun Zhang; Dequan Yu; Qiuju Shao; Jun Liang; Mingxin Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

6.  miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression.

Authors:  Yuan-Fei Ren; Tie-Hui Zhang; Sheng Zhong; Yan-Tao Zhao; Ya-Nan Lv
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

7.  miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.

Authors:  Pingping Tao; Hao Wen; Binlie Yang; Ai Zhang; Xiaohua Wu; Qing Li
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

8.  miR-874 suppresses the proliferation and metastasis of osteosarcoma by targeting E2F3.

Authors:  Dong Dong; Yubao Gong; Debao Zhang; Huricha Bao; Guishan Gu
Journal:  Tumour Biol       Date:  2015-12-02

9.  VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin.

Authors:  Feng Liu; Jihong Wang; Qiang Fu; Xinru Zhang; Ying Wang; Jialin Liu; Jianwen Huang; Xiangguo Lv
Journal:  Tumour Biol       Date:  2015-11-13

10.  [Role of miR-144-3p and its target gene in regulating osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro].

Authors:  Jin Lu; Haoxuan Zhang; Peng Yu; Yifeng Gong; Xiwang Gong; Qiangqiang Fan; Yue Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.